CTI BioPharma Corp.
(NASDAQ : CTIC)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SAVACassava Sciences, Inc. -3.95%50.970.0%$769.17m
GWPHGW Pharmaceuticals Plc 0.12%215.256.1%$387.35m
HZNPHorizon Therapeutics Plc -4.18%91.495.6%$195.25m
JAZZJazz Pharmaceuticals Plc -0.99%171.782.3%$186.59m
VRXValeant Pharmaceuticals International, Inc. 0.45%31.1914.1%$183.53m
BHCBausch Health Cos., Inc. 0.45%31.190.0%$141.85m
CTLTCatalent, Inc. -2.09%112.742.1%$111.36m
ARGXargenx SE 0.48%338.500.0%$83.24m
ICLRICON plc -2.92%186.794.2%$77.03m
TNXPTonix Pharmaceuticals Holding Corp. 0.00%1.250.2%$71.60m
ZYNEZynerba Pharmaceuticals, Inc. -8.41%4.596.0%$59.77m
AMRNAmarin Corp. Plc -2.74%7.101.5%$55.84m
PRGOPerrigo Co. Plc -2.03%40.826.8%$51.21m
PBHPrestige Consumer Healthcare, Inc. -0.12%42.024.0%$48.31m
UTHRUnited Therapeutics Corp. -1.89%170.4114.1%$45.23m

Company Profile

CTI BioPharma Corp. is a biopharmaceutical company, which focuses on the development, acquisition and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA.